These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25210877)

  • 21. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
    Komminoth P
    Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
    Marini F; Giusti F; Tonelli F; Brandi ML
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
    Ramamoorthy B; Nilubol N
    Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
    Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1).
    Lopez CL; Joos B; Bartsch DK; Manoharan J; Albers M; Slater EP; Bollmann C; Roth S; Bayer A; Fendrich V
    World J Surg; 2019 Mar; 43(3):831-838. PubMed ID: 30600364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
    Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
    Marini F; Giusti F; Fossi C; Cioppi F; Cianferotti L; Masi L; Boaretto F; Zovato S; Cetani F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Loli P; Mantero F; Marcocci C; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Guizzardi F; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2018 Oct; 62(1):215-233. PubMed ID: 29497973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
    Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
    Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
    Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
    Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
    Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-exome sequencing as a tool for searching for genetic background modifiers in MEN1 patients with neuroendocrine pancreatic tumours, including insulinomas.
    Skalniak A; Trofimiuk-Müldner M; Jabrocka-Hybel A; Totoń-Żurańska J; Wołkow P; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2023; 74(1):31-46. PubMed ID: 36847722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple endocrine neoplasia type 1 (MEN1).
    Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
    Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
    Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical genetics of neuroendocrine tumors].
    Karges W; Adler G
    Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1.
    Stålberg P; Grimfjärd P; Santesson M; Zhou Y; Lindberg D; Gobl A; Oberg K; Westin G; Rastad J; Wang S; Skogseid B
    J Clin Endocrinol Metab; 2004 May; 89(5):2326-37. PubMed ID: 15126560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.
    Lopez CL; Albers MB; Bollmann C; Manoharan J; Waldmann J; Fendrich V; Bartsch DK
    World J Surg; 2016 Jul; 40(7):1729-36. PubMed ID: 26956903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.
    Sakurai A; Murakami A; Sano K; Uchino S; Fukushima Y
    Endocr J; 2009; 56(7):887-95. PubMed ID: 19564705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.